Artificial intelligence has emerged as a potential solution to inconsistent reporting of adverse events, which to this day ...

The Barcelona-based startup Sequentia Biotech has raised €10 million ($11 million) in a Series A round to finance the ...

The Barcelona-based startup Sequentia Biotech has raised €10 million ($11 million) in a Series A round to finance the development of its omics-based technology for use in biomedicine, agritech and ...

Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration ...

Joaquima Guix Salichs is the director of engineering and extraction technology at Bioiberica, where she leads a team of ...

These results back up results from the TEMPO-3 trial, which tested tavapadon as an add-on therapy to levodopa and which also ...

The US big pharma company Pfizer has voluntarily withdrawn the oral sickle cell disease treatment Oxbryta from the market and halted clinical trials of the drug as data indicate a high risk of severe ...

The small molecule drug arimoclomol (Miplyffa) has got the green light from the U.S. Food and Drug Administration (FDA) for the treatment of the rare disease Niemann-Pick disease type C (NPC), which ...

The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will now file with the FDA. Biohaven, which spun out of Biohaven Pharmaceuticals ...